Breast Cancer

Denial is a very powerful thing, but it is one that can have serious negative consequences.

The addition of postsurgical Verzenio to endocrine therapy provided a benefit in HR–positive, HER2-negative breast cancer.

Shopping for prostheses reminded me of being in a very popular old toy store.

Trodelvy plus Keytruda may maintain quality of life and slow physical decline in metastatic triple-negative breast cancer.

Antibody-drug conjugate treatment rates increased 3.7-fold from 2021 to 2023 for patients with metastatic breast cancer.

Enhertu plus Perjeta improved progression-free survival versus THP in patients with HER2-positive advanced or metastatic breast cancer across subgroups.

Sac-TMT improved progression-free survival in patients with HR+/HER2– breast cancer.

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early breast cancer.

Enhertu led to a 53% reduction in the risk of invasive disease or death versus Kadcyla in some patients with high-risk, HER2-positive breast cancer.

In patients with ER-positive, HER2-negative advanced breast cancer, giredestrant and Afinitor reduced risk of disease progression or death.

Adding Kisqali to a nonsteroidal aromatase inhibitor continued to reduce recurrence risk and improve survival at five years in early breast cancer.

Home-based supervised physical activity has no major impact on fatigue and quality of life for patients with metastatic cancer receiving oral targeted therapy.

During her radiation treatments, Sister Monica Marcinak found grace, humor and deep compassion among fellow patients and caregivers facing cancer together.

I view Breast Cancer Awareness Month as a time to share hope, connection, and stories that remind others life after cancer is possible.

Dr. Evan Garfein explains how 3D printing and tissue-engineered implants could make breast reconstruction safer and less taxing on the body.

CURE spoke with Dr. Komal Jhaveri about the findings of the EMBER-3 clinical trial.

Dr. Evan Garfein discussed OnPlant, a 3D breast model, and stressed timely reconstructive care for all patients during Breast Cancer Awareness Month.

The DONNA Foundation will host its signature fall event, the DONNA 5K at TPC Sawgrass.

I share my journey facing breast cancer at 39, learning my numbers, trusting my doctor, and becoming my own advocate for informed treatment choices.

Jennie Smythe continues the conversation following her initial discussion on early detection self-advocacy during Breast Cancer Awareness Month.

Young women with breast cancer experience significant declines in body image, sexual satisfaction, and sexual interest both during and after treatment.

As a survivor, I see pink ribbons everywhere, but what we really need is more research, better treatments, and real change for those living with cancer.

Dr. Evan Garfein said 3D printing and tissue-engineered implants may make breast reconstruction safer, more personalized and less physically taxing.

It’s October, and social media sites are full of vendors selling merchandise featuring pink ribbons. But here's the thing...

In locally recurrent inoperable or metastatic TNBC, Datroway resulted in improvement in overall survival and progression-free survival.